List of Abbreviations CI confidence interval cervical intraepithelial neoplasia grade ≥2 CIN2+ cervical intraepithelial neoplasia grade ≥3 CIN3+ CRF case report form DHB District Health Board GP general practitioner HPV human papillomavirus hrHPV high risk human papillomavirus LBC liquid-based cytology National Cervical Screening Programme NCSP polymerase chain reaction PCR PHO Primary Health Organisation SAE serious adverse event STI sexually transmitted infection WOW Te Whānau o Waipareira The New Zealand National Cervical Screening Programme (NCSP) has been established for 27 years. Although cervical cancer incidence has declined in both and non-Māori, Māori invasive disease persists, predominantly women who are not screened or who are screened., Cervical cancer is the fifth most common cancer type in women, and Māori cervical cancer registration and mortality rates in women are two-fold higher than Māori those in non-Māori women. The cervical screening coverage rate of women in the Auckland and Waitemata Māori District Health Boards (DHBs) is currently the lowest and third lowest of all DHBs in the country, at 56.4% and 59.2%, respectively. This requires 2,373 and 2,673 more Māori women in each respective DHB to be screened to reach the national coverage target of 80%. Large ethnic inequalities in cervical cancer outcomes and in access to cervical screening services (as measured by coverage) are longstanding and unacceptable (see Figure 1). Figure 1 Cervical screening coverage. Source NCSP. Reasons for low programme participation include cost, embarrassment, time, inconvenience, and discomfort. Actions to reduce these barriers, including no-cost targeted testing (‘free and tailored practice-level data-matching with support, have been undertaken in an smears’) Auckland regional cervical screening coordination approach since 2012; despite these measures there has been very little change in coverage for women. Novel strategies Māori
List of Abbreviations CI confidence interval CIN2+ cervical intraepithelial neoplasia grade ≥2 CIN3+ cervical intraepithelial neoplasia grade ≥3 CRF case report form DHB District Health Board GP general practitioner HPV human papillomavirus hrHPV high risk human papillomavirus LBC liquid-based cytology NCSP National Cervical Screening Programme PCR polymerase chain reaction PHO Primary Health Organisation SAE serious adverse event STI sexually transmitted infection WOW Te Whānau o Waipareira The New Zealand National Cervical Screening Programme (NCSP) has been established for 27 years. Although cervical cancer incidence has declined in both Māori and non-Māori, invasive disease persists, predominantly women who are not screened or who are Cervical cancer is the fifth most common cancer type in Māori women, and cervical cancer registration and mortality rates in Māori women are two-fold higher than those in non-Māori women. The cervical screening coverage rate of Māori women in the Auckland and Waitemata District Health Boards (DHBs) is currently the lowest and third lowest of all DHBs in the country, at 56.4% and 59.2%, respectively. This requires 2,373 and 2,673 more Māori women in each respective DHB to be screened to reach the national coverage target of 80%. Large ethnic inequalities in cervical cancer outcomes and in access to cervical screening services (as measured by coverage) are longstanding and unacceptable (see Figure 1). Figure 1 Cervical screening coverage. Source NCSP. Reasons for low programme participation include cost, embarrassment, time, inconvenience, and discomfort. Actions to reduce these barriers, including no-cost targeted testing (‘free smears’) and tailored practice-level data-matching with support, have been undertaken in an Auckland regional cervical screening coordination approach since 2012; despite these measures there has been very little change in coverage for Māori women. Novel strategies screened.,
371591-5_Protocol_ADHB%20WDHB%20HPVSS_28092016_Final%20v1_11.docx